First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...
NewsNation on MSN
Quarter of all ovarian cancer cases linked to endometriosis: expert
While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...
Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...
Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...
A 54-year-old woman is recovering in hospital in Italy after a 42-pound tumor was removed from one of her ovaries. The patient first went to see her gynecologist after feeling a sense of heaviness and ...
April Powe was diagnosed with ovarian cancer six years ago. “I felt pressure, and bloating, and pain that wouldn’t go away in ...
How Does Lynparza Work for Ovarian Cancer? Lynparza is a type of medicine known as poly (ADP-ribose) polymerase (PARP) inhibitor. PARP is a certain protein that helps cancer cells survive and grow. It ...
1don MSN
One woman tells her story about how incredibly thankful she is after surviving ovarian cancer
SAN ANTONIO — Thanksgiving is a holiday that is centered around gatherings, including food, family, and friends. Meet the San ...
The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers. The FDA has accepted a new drug application ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback